Hudson Bay Capital Management
REVBW icon

Hudson Bay Capital Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Hudson Bay Capital Management’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-693,000
Closed -$612K – 932
2020
Q4 		$612K Buy
+693,000
New +$473K 0.01% 489

Other funds holding REVBW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Hudson Bay Capital Management's REVBW Position: Q1 2021 in Review

Hudson Bay Capital Management sold out of Revelation Biosciences Warrant (REVBW) in Q1 2021, closing a stake of 693,000 shares — an estimated $612K sold.

Hudson Bay Capital Management first reported a position in REVBW in Q4 2020 and held it in 1 quarter. The position peaked at $612K in Q4 2020. 15 funds tracked by Wall St. Rank hold REVBW as of Q1 2021.

  • Hudson Bay Capital Management reported no remaining Revelation Biosciences Warrant position as of Q1 2021 after selling out during the quarter.
  • Hudson Bay Capital Management sold 693,000 Revelation Biosciences Warrant shares in Q1 2021, an estimated $612K.
  • Hudson Bay Capital Management first reported a position in Revelation Biosciences Warrant in Q4 2020 and held it in 1 quarter.
  • Hudson Bay Capital Management's Revelation Biosciences Warrant position peaked at $612K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2021.

Based on Hudson Bay Capital Management's 13F filing for Q1 2021, filed 14 May 2021.